NIO ES9 SUV Launch Sends HK Shares Down 7% Despite Bold Pricing Strategy 
TSMC Posts Strong Q1 2025 Revenue, Riding AI Chip Demand Wave 
Goldman Sachs, ANZ Cut Oil Forecasts Amid U.S.-Iran Ceasefire Hopes 
Apple's Foldable iPhone Faces Engineering Setbacks, Mass Production Timeline at Risk 
LG Electronics Posts Record Q1 Revenue Amid Strong Demand and Cost Improvements 
Ford Issues Major Recall on Over 422,000 Vehicles Due to Windshield Wiper Defect 
Chalco Stock Surges as Q1 2025 Profit Forecast Jumps Up to 58% 
Bank of America Identifies Top Asia-Pacific Semiconductor Stocks Poised for AI-Driven Growth 
Foreign Investors Pour $18.65 Billion into Japanese Stocks Amid Market Stabilization 
Anthropic Fights Pentagon Blacklisting in Dual Federal Court Battles 
China's AI Stocks Surge as Zhipu and MiniMax Hit Record Highs 
Samsung Electronics Posts Eightfold Profit Surge Driven by AI Chip Demand 
China Vanke Seeks Bond Extension Amid Mounting Debt Crisis 
Pershing Square Bids €30.40 Per Share to Acquire Universal Music Group in $9.4B Deal 
Deere & Company Agrees to $99 Million Settlement Over Right-to-Repair Dispute 
Pilots Fear Retaliation for Refusing Middle East Flights Amid Ongoing Conflict 
WATERTOWN, Mass., Jan. 28, 2016 -- A U.S. District Court of Massachusetts jury verdict has found Kaz USA, Inc. of Southborough, MA, a subsidiary of Helen of Troy, Ltd of Hamilton, Bermuda, and the supplier of the Vicks V977 Forehead Thermometer and the Braun FHT1000 Forehead Thermometer, to have infringed United States Patent Nos. 6,292,685 (‘685 patent) and 7,787,938 (‘938 patent) owned by Exergen Corporation. All 12 claims asserted, including three claims in the ‘685 patent and nine claims in the ‘938 patent, were found valid and infringed. The infringing Vicks and Braun forehead thermometers are made in China, designed and manufactured by Microlife Corporation of Taipei, Taiwan, and sold to retailers by Kaz USA.
After a two week trial and four hours of deliberation, the eight person federal jury entered a unanimous verdict for Exergen in all 65 questions placed before the jury regarding direct infringement, induced infringement, contributory infringement, patent validity, and damages owed to Exergen.
A recognized world leader in medical and industrial non-invasive temperature technologies, Exergen has been developing and patenting its non-invasive thermometer technology for three decades. The company’s Founder and President Francesco Pompei, Ph.D, also a Harvard research scientist, is the inventor of over 60 issued United States patents.
“I started Exergen in my basement to develop new heat sensing technology in 1980 and since then have developed non-invasive temperature sensors that are used in a multitude of applications, from home and professional medical thermometers to heat sensors used by NASA,” says Dr. Pompei. “We are pleased that the U.S. Patent System and the Federal Courts make it possible for small companies like Exergen to protect our breakthrough patented technology and years of work to gain market acceptance from infringement by much larger companies and those who wished to ‘step on Exergen’s throat,’ as trial testimony indicated.”
Exergen’s patented award-winning TemporalScanner™ temporal artery thermometers are manufactured in Watertown, MA from components and materials sourced worldwide. They are relied upon for fast, accurate, non-invasive temperatures in thousands of hospitals and clinics and millions of homes. With more than 50 published clinical studies attesting to accuracy for all ages and all areas of medical care, the Exergen TemporalScanner is the #1 thermometer in proven accuracy, and the #1 preference of pediatricians, nurses, and moms.
Contact: Melissa Rubin Rosica Public Relations [email protected] P: 201.843.5600 F: 201.843.5680 95 Route 17 South, Suite 202 Paramus, New Jersey 07652
